282 related articles for article (PubMed ID: 21356384)
1. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.
Li A; King J; Moro A; Sugi MD; Dawson DW; Kaplan J; Li G; Lu X; Strieter RM; Burdick M; Go VL; Reber HA; Eibl G; Hines OJ
Am J Pathol; 2011 Mar; 178(3):1340-9. PubMed ID: 21356384
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
[TBL] [Abstract][Full Text] [Related]
3. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
[TBL] [Abstract][Full Text] [Related]
4. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
6. Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways.
Cui D; Zhao Y; Xu J
Cancer Biol Ther; 2019; 20(5):608-616. PubMed ID: 30404567
[TBL] [Abstract][Full Text] [Related]
7. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
Ando Y; Ohuchida K; Otsubo Y; Kibe S; Takesue S; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Oda Y; Nakamura M
PLoS One; 2020; 15(1):e0228015. PubMed ID: 31999765
[TBL] [Abstract][Full Text] [Related]
8. CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.
Chao T; Furth EE; Vonderheide RH
Cancer Immunol Res; 2016 Nov; 4(11):968-982. PubMed ID: 27737879
[TBL] [Abstract][Full Text] [Related]
9. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
[TBL] [Abstract][Full Text] [Related]
10. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
Gao Y; Guan Z; Chen J; Xie H; Yang Z; Fan J; Wang X; Li L
Int J Oncol; 2015 Aug; 47(2):690-700. PubMed ID: 26058729
[TBL] [Abstract][Full Text] [Related]
11. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.
Matsuo Y; Raimondo M; Woodward TA; Wallace MB; Gill KR; Tong Z; Burdick MD; Yang Z; Strieter RM; Hoffman RM; Guha S
Int J Cancer; 2009 Sep; 125(5):1027-37. PubMed ID: 19431209
[TBL] [Abstract][Full Text] [Related]
12. CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
Feng X; Zhang D; Li X; Ma S; Zhang C; Wang J; Li Y; Liang L; Zhang P; Qu Y; Zhang Z; Yang Z; Xiang Y; Zhang W; Wang S; Shao W; Wang W
Biomed Pharmacother; 2018 Nov; 107():1496-1504. PubMed ID: 30257367
[TBL] [Abstract][Full Text] [Related]
13. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS; Rocha F; Matros E; Redston M; Whang E
Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between head and neck cancer cells and lymphatic endothelial cells promotes tumor metastasis via CXCL5-CXCR2 signaling.
Lee BS; Jang JY; Seo C; Kim CH
FASEB J; 2021 Jan; 35(1):e21181. PubMed ID: 33231340
[TBL] [Abstract][Full Text] [Related]
15. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis.
Zhou Z; Xia G; Xiang Z; Liu M; Wei Z; Yan J; Chen W; Zhu J; Awasthi N; Sun X; Fung KM; He Y; Li M; Zhang C
Clin Cancer Res; 2019 Jun; 25(11):3317-3328. PubMed ID: 30796034
[TBL] [Abstract][Full Text] [Related]
16. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
Okabe H; Beppu T; Ueda M; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Mima K; Miyake K; Iwatsuki M; Baba Y; Takamori H; Jono H; Shinriki S; Ando Y; Baba H
Int J Cancer; 2012 Nov; 131(10):2234-41. PubMed ID: 22337081
[TBL] [Abstract][Full Text] [Related]
17. Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1.
Bocci G; Fioravanti A; Orlandi P; Di Desidero T; Natale G; Fanelli G; Viacava P; Naccarato AG; Francia G; Danesi R
Neoplasia; 2012 Sep; 14(9):833-45. PubMed ID: 23019415
[TBL] [Abstract][Full Text] [Related]
18. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.
Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W
Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression.
Kuo PL; Huang MS; Hung JY; Chou SH; Chiang SY; Huang YF; Yang CJ; Tsai MJ; Chang WA; Hsu YL
Int J Cancer; 2014 Jul; 135(1):96-108. PubMed ID: 24346967
[TBL] [Abstract][Full Text] [Related]
20. Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression.
Wang ZZ; Li XT; Li QJ; Zhou JX
Dig Dis Sci; 2023 Mar; 68(3):841-851. PubMed ID: 35650416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
